Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS

计划入组 17 人 · 首次发布于 2020 年 7 月 31 日

Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients

计划入组 76 人 · 首次发布于 2024 年 7 月 9 日

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)

计划入组 10 人 · 首次发布于 2025 年 8 月 20 日

Umbilical cord derived mesenchymal stem cell therapy (Restem)

Umbilical Cord Blood Stem Cell

umbilical cord lining stem cells

Stem Cell Therapeutics Corp

Canada

Stem Cell Medicine Ltd.

Israel

PT. Prodia Stem Cell Indonesia

RESTEM Receives FDA Orphan Drug Designation for Stem Cell Therapy in Polymyositis Treatment

RESTEM's ULSC Program Receives FDA Orphan Drug Designation for Polymyositis and Dermatomyositis

RESTEM's Restem-L Receives FDA Fast Track Designation for Idiopathic Inflammatory Myopathy